Patent details

EP2152754 Title: MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER

Basic Information

Publication number:
EP2152754
PCT Application Number:
EP2008004197
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087587820
PCT Publication Number:
WO2008145338
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER
French Title of Invention:
ANTICORPS MONOCLONAUX DIRIGÉS CONTRE LA CLAUDINE-18 POUR LE TRAITEMENT DU CANCER
German Title of Invention:
MONOKLONALE ANTIKÖRPER GEGEN CLAUDIN-18 ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
27/05/2008
Grant date:
25/04/2018
EP Publication Date:
17/02/2010
PCT Publication Date:
04/12/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/04/2018
EP B1 Publication Date:
25/04/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/05/2018
Expiration date:
27/05/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/06/2018
 
 

Name:
Astellas Pharma Inc.
Address:
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo 103-8411, Japan (JP)

Name:
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
Address:
Freiligrathstrasse 12, 55131 Mainz, Germany (DE)

History of Owners

From:
25/05/2018
To:
22/06/2018

Name:
Ganymed Pharmaceuticals GmbH
Address:
An der Goldgrube 12, 55131 Mainz, Germany (DE)

Name:
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
Address:
Freiligrathstrasse 12, 55131 Mainz, Germany (DE)

From:
20/04/2018
To:
25/05/2018

Name:
Ganymed Pharmaceuticals GmbH
Address:
An der Goldgrube 12, 55131 Mainz, Germany (DE)

Name:
Johannes-Gutenberg-Universität Mainz
Address:
Saarstrasse 21, 55122 Mainz, Germany (DE)

From:
18/04/2018
To:
20/04/2018

Name:
Ganymed Pharmaceuticals AG
Address:
An der Goldgrube 12, 55131 Mainz, Germany (DE)

Name:
Johannes-Gutenberg-Universität Mainz
Address:
Saarstrasse 21, 55122 Mainz, Germany (DE)

Inventor

1

Name:
TÜRECI, Özlem
Address:
Germany (DE)

2

Name:
USENER, Dirk
Address:
Germany (DE)

3

Name:
SAHIN, Ugur
Address:
Germany (DE)

4

Name:
BRANDENBURG, Gunda
Address:
Germany (DE)

Priority

1

Priority Number:
932099 P
Priority Date:
29/05/2007
Priority Country:
United States (US)

2

Priority Number:
07010622
Priority Date:
29/05/2007
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 39/395; A61P 35/00; C07K 16/30; C12N 5/12;

Publication

European Patent Bulletin

1

Issue number:
201817
Publication date:
25/04/2018
Description:
Grant (B1)

2

Issue number:
201821
Publication date:
23/05/2018
Description:
Transfer of Rights

3

Issue number:
201822
Publication date:
30/05/2018
Description:
Application number/publication number of the divisional application (Art. 76) changed

4

Issue number:
201826
Publication date:
27/06/2018
Description:
Transfer of Rights

5

Issue number:
201827
Publication date:
04/07/2018
Description:
Document reprinted after correction (B8, B9)

6

Issue number:
201830
Publication date:
25/07/2018
Description:
Transfer of Rights

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/09/2018 Outgoing Correspondence 1